Middle East and Africa Kidney Disease Market Segments and Growth by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

Middle East and Africa Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Diagnosis and Treatment); End User (Hospitals, Diagnostic Laboratories, and Others); and Country

Report Date : Nov 2020
Report Code : TIPRE00016075

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 164

Page Updated: Nov 2020

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The Middle East & Africa kidney disease market is expected to reach US$ 7,406.2 million in 2027 from US$ 4,834.1 million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020-2027.

Kidney disease means that the kidneys are damaged and cannot filter blood as they should. This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others.The scope of the kidney disease market includes product, end-user, and region.

Saudi Arabia Kidney Disease Market Revenue and Forecasts to 2027 (US$ MN)

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights

Increased Prevalence of Obesity across the Region

Every country in the Middle East & Africa region is currently facing an increasing prevalence of obesity due to multiple factors. A sedentary lifestyle and unhealthy eating habits contribute majorly to obesity in an individual. Along with a lack of physical activity and mounting stress are contributing as well. According to a report ‘2018ReviewEnd-stage Renal Disease in the Middle East: A Systematic Review and Meta-analysis’, it is estimated that the annual cost for CKD and ESRD is $48 billion and $32.9 billion and is rising due to cases of obesity.As perthe report ‘Chronic Kidney Disease in Arab World: A Call for Action,’obesity is also related to CKD epidemiology since obesity appears to be an essential risk factor for CKD. The prevalence of obesity has increased over the past two decades. Over 3,000 million adults worldwide are obese. The majority of a body mass index of at least 35 among incident dialysis patients has increased by 64% over the past decade. If trends continue, 20% of all patients will initiate dialysis with this degree of obesity. In Syria, obesity was 38.2%, with the prevalence in women nearly one and half times more than in men. Obesity affects 16–50% of individuals with diabetes in the Arab world, 20–38% have hyperlipidemia, 24–46% have hypertension and, although data are incomplete, nephropathy and retinopathy rates appear to be relatively high. Moreover, in a review of obesity prevalence in the Arab world, it was concluded that one-third of Arabs are obese, and women have notably higher rates of obesity as defined by a body mass index of 30.Thus, an increase in the prevalence of obesity in the Middle East & Africa region is likely to create lucrative opportunities for market growth.

Product- Based Market Insights

Based on product,thekidney disease marketis segmented into diagnosis and treatment. The diagnosis segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.

End-User - Based Market Insights

Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Middle East & Africa Kidney Disease Market, by End-User – 2019 and 2027

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Middle East and Africa Kidney Disease Market: Strategic Insights

Middle East and Africa Kidney Disease Market

Market Size 2019
US$ 4,834.1 Million

Market Size 2027
US$ 7,406.2 Million

Market Dynamics

GROWTH DRIVERS
XXXXXXX
XXXXXXX
XXXXXXX

FUTURE TRENDS
XXXXXXX
XXXXXXX
XXXXXXX

OPPORTUNITIES
XXXXXXX
XXXXXXX
XXXXXXX

Regional Overview

Middle East and Africa

Market Segmentation

Product

Diagnosis and Treatment

End User

Hospitals
Diagnostic Laboratories

Get Top Key Market Trends of this report.
This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Middle East and Africa Kidney Disease MarketReport Scope

Middle East and Africa Kidney Disease Market Report Scope

Report Attribute	Details
Market size in 2019	US$ 4,834.1 Million
Market Size by 2027	US$ 7,406.2 Million
Global CAGR (2020 - 2027)	5.5%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Product Diagnosis and Treatment By End User Hospitals Diagnostic Laboratories
Regions and Countries Covered	Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott F. Hoffmann-La Roche Ltd AbbVieInc Pfizer Inc Teva Pharmaceutical Industries Ltd GlaxoSmithKline plc Sysmex Corporation Siemens AG Amgen Inc

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Middle East and Africa Kidney Disease Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy